Basics Ikena Oncology, Inc. Common Stock IPO Date: March 22, 2021 Sector: Healthcare Industry: Biotech Market Cap: $59.9M Activated in VL: True Average Daily Range Avg Daily Range: $0.27 | 4.14% Avg Daily Range (30 D): $0.05 | 3.30% Avg Daily Range (90 D): $0.03 | 2.37% Institutional Daily Volume Avg Daily Volume: .13M Avg Daily Volume (30 D): .02M Avg Daily Volume (90 D): .12M Trade Size Avg Trade Size (Sh.): 115 Avg Trade Size (Sh.) (30 D): 210 Avg Trade Size (Sh.) (90 D): 272 Institutional Trades Total Inst.Trades: 72 Avg Inst. Trade: $1.93M Avg Inst. Trade (30 D): $.59M Avg Inst. Trade (90 D): $.59M Avg Inst. Trade Volume: .35M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.86M Avg Closing Trade (30 D): $4.41M Avg Closing Trade (90 D): $4.41M Avg Closing Volume: 615.09K     News Jul 25, 2025 @ 3:00 PM Inmagene Biopharmaceuticals Announces Completion o... Source: Not Specified Jul 25, 2025 @ 3:00 PM Inmagene Biopharmaceuticals Announces Completion o... Source: Not Specified Jul 15, 2025 @ 8:15 PM Ikena Oncology Announces Stockholder Approval of M... Source: Globe Newswire Dec 23, 2024 @ 1:30 PM Ikena Oncology and Inmagene Biopharmaceuticals Ann... Source: Globe Newswire May 29, 2024 @ 7:33 PM Ikena Oncology Discontinues IK-930 Program And Cut... Source: Vandana Singh Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.64 $-.06 $-.18 Diluted EPS $-.64 $-.06 $-.18 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -30.74M $ -2.77M $ -8.62M Operating Income / Loss $ -44.47M $ -8.75M $ -10.79M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio